News | July 10, 2024
Lilly to acquire Morphic to improve outcomes for patients with inflammatory bowel disease
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
SYNERGY-NASH results were presented at the European Association for the Study of the Liver Congress 2024 and simultaneously published in The New England Journal of Medicine
Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
Ulcerative Colitis (UC) is a chronic, idiopathic, immune-mediated inflammatory bowel disease (IBD) affecting the large intestine
The 200 bedded hospital owned & operated by Alexis
Dr. Mandaviya also laid the foundation stone for an All India Institute of Speech and Hearing (AIISH) Satellite Centre in Kanpur
This acquisition marks Max Healthcare's entry into Lucknow
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Six engaging sessions focusing on Prevention of Kidney Diseases, Brain Stem Death Declaration, Deceased Donor Management, Prevention of Liver Diseases, Legal Aspects of Organ and Tissue Donation, Eye Donation and Corneal Transplant held as part of the Webinar
Subscribe To Our Newsletter & Stay Updated
